Sumgen Biotech
Sumgen Biotech, a leading player in the biotechnology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2015, the company has rapidly established itself as a pioneer in the development of innovative biopharmaceuticals and advanced therapeutics. Specialising in monoclonal antibodies and gene therapies, Sumgen Biotech distinguishes itself through its commitment to cutting-edge research and development. The company’s unique approach to bioprocessing and its robust pipeline of products have garnered significant attention in the industry. With a strong market position, Sumgen Biotech has achieved notable milestones, including successful collaborations with global pharmaceutical firms and recognition for its contributions to healthcare advancements. As it continues to expand its influence, Sumgen Biotech remains dedicated to improving patient outcomes through its transformative solutions.
DitchCarbon Score
How does Sumgen Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sumgen Biotech's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sumgen Biotech's reported carbon emissions
Sumgen Biotech, headquartered in China (CN), currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. As a result, there is no information on their commitments to reducing carbon emissions or any initiatives that may be in place. Without emissions data or reduction initiatives, it is unclear how Sumgen Biotech is addressing climate change within the biotechnology sector. In the absence of specific data, it is essential for the company to consider setting measurable targets and engaging in climate action to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sumgen Biotech is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
